The global gene synthesis market size accounted for USD 3.22 billion in 2024, grew to USD 4 billion in 2025 and is predicted to surpass around USD 27.63 billion by 2034, representing a healthy CAGR of 23.97% between 2024 and 2034. The North America gene synthesis market size is calculated at USD 1.26 billion in 2024 and is expected to grow at a fastest CAGR of 24.15% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Gene Synthesis Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Gene Synthesis Market, by Method, 2024-2034
8.1.1. Solid-phase synthesis
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Chip- based synthesis
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. PCR- based Enzyme synthesis
8.1.3.1. Market Revenue and Forecast (2021-2034)
9.1. Gene Synthesis Market, by Service, 2024-2034
9.1.1. Antibody DNA synthesis
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Viral DNA synthesis
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. Gene Synthesis Market, by Application, 2024-2034
10.1.1. Gene & cell therapy development
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Vaccine development
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Diseases diagnosis
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2021-2034)
11.1. Gene Synthesis Market, by End Users, 2024-2034
11.1.1. Biotechnology & pharmaceutical companies
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Academic & government research institutes
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Contract research organizations
11.1.3.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Method (2021-2034)
12.1.2. Market Revenue and Forecast, by Service (2021-2034)
12.1.3. Market Revenue and Forecast, by Application (2021-2034)
12.1.4. Market Revenue and Forecast, by End Users (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Method (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Service (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End Users (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Method (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Service (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End Users (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Method (2021-2034)
12.2.2. Market Revenue and Forecast, by Service (2021-2034)
12.2.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.4. Market Revenue and Forecast, by End Users (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Method (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Service (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End Users (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Method (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Service (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End Users (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Method (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Service (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End Users (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Method (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Service (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Application (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End Users (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Method (2021-2034)
12.3.2. Market Revenue and Forecast, by Service (2021-2034)
12.3.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.4. Market Revenue and Forecast, by End Users (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Method (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Service (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End Users (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Method (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Service (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End Users (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Method (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Service (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End Users (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Method (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Service (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Application (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End Users (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Method (2021-2034)
12.4.2. Market Revenue and Forecast, by Service (2021-2034)
12.4.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.4. Market Revenue and Forecast, by End Users (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Method (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Service (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End Users (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Method (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Service (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End Users (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Method (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Service (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End Users (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Method (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Service (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Application (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End Users (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Method (2021-2034)
12.5.2. Market Revenue and Forecast, by Service (2021-2034)
12.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.5.4. Market Revenue and Forecast, by End Users (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Method (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Service (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End Users (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Method (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Service (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Application (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End Users (2021-2034)
13.1. OriGene Technologies,Inc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Integrated DNA Technologies, Inc
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Thermo Fisher Scientific, Inc
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. ProMab Biotechnologies, Inc
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Eurofins Scientific
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Biomatik
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. ProteoGenix
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Bosyer Biological Technology
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. GenScript
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Brooks Automation, Inc
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample